Christopher M Verdier

Array ( [id] => 17343598 [patent_doc_number] => 20220009929 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2022-01-13 [patent_title] => POLYMORPHIC FORMS OF IBRUTINIB [patent_app_type] => utility [patent_app_number] => 17/052226 [patent_app_country] => US [patent_app_date] => 2019-05-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4277 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052226 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19503755 [patent_doc_number] => 12115153 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-10-15 [patent_title] => Methods of treating cancer [patent_app_type] => utility [patent_app_number] => 17/052040 [patent_app_country] => US [patent_app_date] => 2019-04-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 45947 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17052040 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16476194 [patent_doc_number] => 10851122 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-01 [patent_title] => Method for producing an ionic liquid [patent_app_type] => utility [patent_app_number] => 16/397135 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7305 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 54 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16397135 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16244807 [patent_doc_number] => 10744133 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-08-18 [patent_title] => Compound for anti-cancer therapy that acts by targeting GOF mutant p53 and stimulates p73 to restore the p53 pathway signaling [patent_app_type] => utility [patent_app_number] => 16/396829 [patent_app_country] => US [patent_app_date] => 2019-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 22885 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 81 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396829 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15363475 [patent_doc_number] => 20200017502 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => METHODS AND REAGENTS FOR RADIOLABELING [patent_app_type] => utility [patent_app_number] => 16/396496 [patent_app_country] => US [patent_app_date] => 2019-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10677 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -23 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16396496 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 15363555 [patent_doc_number] => 20200017542 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2020-01-16 [patent_title] => NEUROACTIVE STEROIDS, COMPOSITIONS, AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/393396 [patent_app_country] => US [patent_app_date] => 2019-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 43279 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -13 [patent_words_short_claim] => 2 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16393396 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 19311541 [patent_doc_number] => 12037344 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-07-16 [patent_title] => NLRP3 modulators [patent_app_type] => utility [patent_app_number] => 17/049612 [patent_app_country] => US [patent_app_date] => 2019-04-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 102048 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 1020 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049612 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16711803 [patent_doc_number] => 20210078950 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-03-18 [patent_title] => METHOD FOR THE HYDROLYSIS OF QUINOLONECARBOXYLIC ESTERS [patent_app_type] => utility [patent_app_number] => 17/049925 [patent_app_country] => US [patent_app_date] => 2019-04-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3472 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -8 [patent_words_short_claim] => 165 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17049925 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16532164 [patent_doc_number] => 10874740 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-12-29 [patent_title] => 5-ALA derivatives and use thereof [patent_app_type] => utility [patent_app_number] => 16/384137 [patent_app_country] => US [patent_app_date] => 2019-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 18796 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 235 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16384137 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14652487 [patent_doc_number] => 20190233372 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => Carbondisulfide Derived Zwitterions [patent_app_type] => utility [patent_app_number] => 16/383075 [patent_app_country] => US [patent_app_date] => 2019-04-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4421 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -10 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16383075 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16563215 [patent_doc_number] => 10888562 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-01-12 [patent_title] => AXL kinase inhibitors and use of the same [patent_app_type] => utility [patent_app_number] => 16/376452 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 174 [patent_no_of_words] => 89660 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16563215 [patent_doc_number] => 10888562 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-01-12 [patent_title] => AXL kinase inhibitors and use of the same [patent_app_type] => utility [patent_app_number] => 16/376452 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 174 [patent_no_of_words] => 89660 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14652559 [patent_doc_number] => 20190233408 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-08-01 [patent_title] => INDOLE DERIVATIVES AS ESTROGEN RECEPTOR DEGRADERS [patent_app_type] => utility [patent_app_number] => 16/376225 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33391 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -19 [patent_words_short_claim] => 55 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376225 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16563215 [patent_doc_number] => 10888562 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-01-12 [patent_title] => AXL kinase inhibitors and use of the same [patent_app_type] => utility [patent_app_number] => 16/376452 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 174 [patent_no_of_words] => 89660 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16563215 [patent_doc_number] => 10888562 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2021-01-12 [patent_title] => AXL kinase inhibitors and use of the same [patent_app_type] => utility [patent_app_number] => 16/376452 [patent_app_country] => US [patent_app_date] => 2019-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 109 [patent_figures_cnt] => 174 [patent_no_of_words] => 89660 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16376452 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16839331 [patent_doc_number] => 20210147343 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2021-05-20 [patent_title] => OPIOID RECEPTOR MODULATORS AND PRODUCTS AND METHODS RELATED THERETO [patent_app_type] => utility [patent_app_number] => 17/045152 [patent_app_country] => US [patent_app_date] => 2019-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 53314 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -98 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17045152 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 16414426 [patent_doc_number] => 10822301 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2020-11-03 [patent_title] => 3-carbon substituted 4-aminocyclopent-1-ene-1-carboxylic acid compounds as inhibitors of gamma-aminobutyric acid (GABA) aminotransferase [patent_app_type] => utility [patent_app_number] => 16/375469 [patent_app_country] => US [patent_app_date] => 2019-04-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7124 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16375469 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 17875458 [patent_doc_number] => 11447459 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2022-09-20 [patent_title] => Use of substituted chroman-6-ols with extended lipophilic side chains [patent_app_type] => utility [patent_app_number] => 17/041910 [patent_app_country] => US [patent_app_date] => 2019-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10534 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 14896785 [patent_doc_number] => 20190292158 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2019-09-26 [patent_title] => SUBSTITUTED PHENYL SULFONYL PHENYL TRIAZOLE THIONES AND USES THEREOF [patent_app_type] => utility [patent_app_number] => 16/366793 [patent_app_country] => US [patent_app_date] => 2019-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29652 [patent_no_of_claims] => 0 [patent_no_of_ind_claims] => -29 [patent_words_short_claim] => 70 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16366793 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 18980080 [patent_doc_number] => 11905240 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2024-02-20 [patent_title] => Cyclopropyl ethylene compound and arthropod pest control composition containing same [patent_app_type] => utility [patent_app_number] => 17/041205 [patent_app_country] => US [patent_app_date] => 2019-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 22832 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 161 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17041205 [rel_patent_id] =>[rel_patent_doc_number] =>)